Skip to main content
. 2022 Apr 1;53(6):2006–2015. doi: 10.1161/STROKEAHA.121.035826

Figure 2.

Figure 2.

Shows the individual data points for vasomotor reactivity parameters at baseline and follow-up. Blood-oxygen-level-dependent (BOLD) amplitude (A), time to peak (B) and time to baseline (C) are shown. Presymptomatic Dutch-type hereditary cerebral amyloid angiopathy (D-CAA) mutation carriers are represented in blue, symptomatic mutation carriers in red, and controls in green. Significant longitudinal differences are shown with an asterisk.